Observational Study of Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patients With Cataracts

Clinical Trial

Offered by: Nemours
Locations: Jacksonville, Fla.

Trial Name

Observational Study of Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patients With Cataracts

What is the trial about?

The purpose of the study is to better understand how many people who have been diagnosed with early-onset idiopathic bilateral cataracts may have a rare, but treatable disease called Cerebrotendinous Xanthomatosis (CTX). CTX  is a disease where you do not make bile acids normally.

Who can participate?

Anyone between the ages of 2 and 21 years old, who was diagnosed with early-onset (affects someone younger than the expected age) idiopathic (unknown cause) bilateral (in both eyes) cataracts (clouding of the eye's natural lens).

What is involved?

The study has 1 clinic visit at which time we will collect a blood and optional urine sample from your child. Once the blood has been drawn, your child's participation will last until the doctor notifies you of the results of the testing, usually about 4-8 weeks after the visit.

Contact Nemours Clinical Trials

Trial Name: Observational Study of Prevalence of Cerebrotendinous Xanthomatosis (CTX) in Patients With Cataracts

Contact Information

(800) 354-5690
ClinicalTrials@nemours.org